Bedrosian Camille L bought CRNX
June 18, 2026 · Form 4 insider transaction
Bedrosian Camille L bought 5,925 shares of Crinetics Pharmaceuticals Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,925
Price
$0.00
Total value
N/A
InsiderBedrosian Camille L
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 18, 2026
Filing dateJune 22, 2026
Shares owned after22,225
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.